Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Double

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|February 1, 1992
Selectivity and potency; are we doing the right things to find anti-cancer agents with these properties?J A Double
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1975
Human tumour xenograftsJ A Double
Biochemical Pharmacology|January 15, 1978
Enzyme activated anti-tumor agents--IV. Comparative kinetics of N,N-p-di-2-chloroethylaminophenyl phosphate hydrolysis catalysed by phosphatases of normal and neoplastic tissuesP Workman, J A Double
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|October 1, 1978
Drug latentiation in cancer chemotherapyP Workman, J A Double
Cancer Treatment Reports|August 1, 1977
A new high-glucuronidase mouse tumor curable by aniline mustard therapyJ A Double, P Workman
Anti-Cancer Drugs|February 1, 1993
Flavone acetic acid--from laboratory to clinic and backM C Bibby, J A Double
Journal of the National Cancer Institute|July 5, 1989
Therapeutic index: a vital component in selection of anticancer agents for clinical trialJ A Double, M C Bibby
British Journal of Cancer|February 1, 1975
Proceedings: Transplantable adenocarcinomata of the colon in mice as possible models for chemotherapyC R Ball, J A Double
Biochemical Pharmacology|November 15, 1974
Enzyme activated anti-tumour agents. Conjugates of p-hydroxyaniline mustard as substrates for hydrolytic enzymesC R Ball, J A Double
British Journal of Cancer|February 1, 1975
Proceedings: Influence of transplantation site on the establishment of human tumour xenografts in immunosuppressed miceJ A Double, C R Ball
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|February 1, 1992
Selectivity and potency; are we doing the right things to find anti-cancer agents with these properties?J A Double
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|November 1, 1975
Human tumour xenograftsJ A Double
Biochemical Pharmacology|January 15, 1978
Enzyme activated anti-tumor agents--IV. Comparative kinetics of N,N-p-di-2-chloroethylaminophenyl phosphate hydrolysis catalysed by phosphatases of normal and neoplastic tissuesP Workman, J A Double
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|October 1, 1978
Drug latentiation in cancer chemotherapyP Workman, J A Double
Cancer Treatment Reports|August 1, 1977
A new high-glucuronidase mouse tumor curable by aniline mustard therapyJ A Double, P Workman
Anti-Cancer Drugs|February 1, 1993
Flavone acetic acid--from laboratory to clinic and backM C Bibby, J A Double
Journal of the National Cancer Institute|July 5, 1989
Therapeutic index: a vital component in selection of anticancer agents for clinical trialJ A Double, M C Bibby
British Journal of Cancer|February 1, 1975
Proceedings: Transplantable adenocarcinomata of the colon in mice as possible models for chemotherapyC R Ball, J A Double
Biochemical Pharmacology|November 15, 1974
Enzyme activated anti-tumour agents. Conjugates of p-hydroxyaniline mustard as substrates for hydrolytic enzymesC R Ball, J A Double
British Journal of Cancer|February 1, 1975
Proceedings: Influence of transplantation site on the establishment of human tumour xenografts in immunosuppressed miceJ A Double, C R Ball
Pageof 10